111 related articles for article (PubMed ID: 32003759)
1. Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Cao JY; Guo Q; Guan GF; Zhu C; Zou CY; Zhang LY; Cheng W; Wang GL; Cheng P; Wu AH; Li GY
Aging (Albany NY); 2020 Jan; 12(2):1656-1684. PubMed ID: 32003759
[TBL] [Abstract][Full Text] [Related]
2. ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
Lailler C; Louandre C; Morisse MC; Lhossein T; Godin C; Lottin M; Constans JM; Chauffert B; Galmiche A; Saidak Z
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467175
[TBL] [Abstract][Full Text] [Related]
3. Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.
Chen AX; Gartrell RD; Zhao J; Upadhyayula PS; Zhao W; Yuan J; Minns HE; Dovas A; Bruce JN; Lasorella A; Iavarone A; Canoll P; Sims PA; Rabadan R
Genome Med; 2021 May; 13(1):88. PubMed ID: 34011400
[TBL] [Abstract][Full Text] [Related]
4. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
Cooper LA; Gutman DA; Chisolm C; Appin C; Kong J; Rong Y; Kurc T; Van Meir EG; Saltz JH; Moreno CS; Brat DJ
Am J Pathol; 2012 May; 180(5):2108-19. PubMed ID: 22440258
[TBL] [Abstract][Full Text] [Related]
5. FBP1 is a potential prognostic biomarker and correlated with tumor immunosuppressive microenvironment in glioblastoma.
Sun H; Zhang H; Jing L; Zhao H; Chen B; Song W
Neurosurg Rev; 2023 Jul; 46(1):187. PubMed ID: 37507483
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma.
Sun MA; Yao H; Yang Q; Pirozzi CJ; Chandramohan V; Ashley DM; He Y
PLoS One; 2024; 19(3):e0299820. PubMed ID: 38507437
[TBL] [Abstract][Full Text] [Related]
7. Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics.
Xing J; Cai H; Lin Z; Zhao L; Xu H; Song Y; Wang Z; Liu C; Hu G; Zheng J; Ren L; Wei Z
Front Immunol; 2023; 14():1288137. PubMed ID: 38274828
[TBL] [Abstract][Full Text] [Related]
8. HK3 stimulates immune cell infiltration to promote glioma deterioration.
Li S; Li Z; Wang X; Zhong J; Yu D; Chen H; Ma W; Liu L; Ye M; Shen R; Jiang C; Meng X; Cai J
Cancer Cell Int; 2023 Oct; 23(1):227. PubMed ID: 37779195
[TBL] [Abstract][Full Text] [Related]
9. PLEKHA4 promotes glioblastoma progression through apoptosis inhibition, tumor cell migration, and macrophage infiltration.
He Y; Zheng W; Huo Y; Sa L; Zhang H; He G; Shang P
Immunobiology; 2023 Nov; 228(6):152746. PubMed ID: 37980830
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.
Liang X; Wang Z; Dai Z; Liu J; Zhang H; Wen J; Zhang N; Zhang J; Luo P; Liu Z; Liu Z; Cheng Q
Clin Immunol; 2024 Jan; 258():109802. PubMed ID: 37866784
[TBL] [Abstract][Full Text] [Related]
11. Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma.
Jiang J; Duan R; Zhu J; Yan J; Ye J; Luo C
Neuromolecular Med; 2024 May; 26(1):21. PubMed ID: 38750318
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma microenvironment-from biology to therapy.
Read RD; Tapp ZM; Rajappa P; Hambardzumyan D
Genes Dev; 2024 May; ():. PubMed ID: 38811170
[TBL] [Abstract][Full Text] [Related]
13. LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway.
Liu Y; Ma L; Shangguan F; Zhao X; Wang W; Gao Z; Zhou H; Qu G; Huang Y; An J; Xue J; Yang S; Cao Q
Aging (Albany NY); 2020 Sep; 12(16):16142-16154. PubMed ID: 32628130
[TBL] [Abstract][Full Text] [Related]
14. IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
Zhu C; Chen X; Guan G; Zou C; Guo Q; Cheng P; Cheng W; Wu A
Onco Targets Ther; 2020; 13():1129-1143. PubMed ID: 32103982
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.
Shen S; Yan Z; Wu J; Liu X; Guan G; Zou C; Guo Q; Zhu C; Liu T; Chen C; Chen L; Cheng P; Cheng W; Wu A
Front Oncol; 2020; 10():581197. PubMed ID: 33194713
[No Abstract] [Full Text] [Related]
16. Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8
Peng DH; Rodriguez BL; Diao L; Chen L; Wang J; Byers LA; Wei Y; Chapman HA; Yamauchi M; Behrens C; Raso G; Soto LMS; Cuentes ERP; Wistuba II; Kurie JM; Gibbons DL
Nat Commun; 2020 Sep; 11(1):4520. PubMed ID: 32908154
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.
Wang W; Han S; Gao W; Feng Y; Li K; Wu D
Cell Mol Neurobiol; 2022 Apr; 42(3):695-708. PubMed ID: 32897512
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1.
Xu L; Wang S; Li J; Li J; Li B
Oncoimmunology; 2020 Apr; 9(1):1740477. PubMed ID: 33457088
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of ARL9 and its methylation in low-grade glioma.
Tan Y; Zhang S; Xiao Q; Wang J; Zhao K; Liu W; Huang K; Tian W; Niu H; Lei T; Shu K
Genomics; 2020 Nov; 112(6):4808-4816. PubMed ID: 32882327
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches.
Kalluri AL; Shah PP; Lim M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
